Literature DB >> 3088700

[Treatment of amyotrophic lateral sclerosis with thyrotropin releasing hormone].

G Serratrice, C Desnuelle, A Crevat, C Guelton, A Meyer-Dutour.   

Abstract

Nine patients (7 with amyotrophic lateral sclerosis, 1 with progressive spinal amyotrophy and 1 with chronic anterior poliomyelitis) were treated by sequential intravenous administration of 240 mg of TRH over one hour every two weeks. Results were assessed by an analytical evaluation of muscle strength before and 24 h after each infusion and by objective and subjective evaluation of spasticity. Significant improvement, as shown by statistical analysis, was noted in muscle strength in the 9 patients by 5 infusions over a 4-week period and a sub-group of 5 patients treated by 8 infusions over 10 weeks. Continued use of this therapy is justified by the need to determine its long-term effects and the psychological improvement noted in some patients after an even transient improvement in motor performance. However this treatment is obviously not curative.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088700

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  4 in total

1.  Low doses of TRH in amyotrophic lateral sclerosis and in other neurological diseases.

Authors:  S Congia; S Tronci; M Ledda; A Porcella; G Coppola
Journal:  Ital J Neurol Sci       Date:  1991-04

2.  Subacute administration of a TRH analogue (RX77368) in motorneuron disease: an open study.

Authors:  H Modarres-Sadeghi; H Rogers; J Emami; R J Guiloff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

3.  Amyotrophic lateral sclerosis: thyroid and prolactin hormone changes in thyrotropin-releasing hormone therapy.

Authors:  D Testa; P G Chiodini; F Girotti; R Attanasio
Journal:  Ital J Neurol Sci       Date:  1990-12

4.  Down-regulation of thyrotropin-releasing hormone (TRH) receptors in spinal cord after transection as revealed by quantitative autoradiography.

Authors:  G Vita; C K Haun; E F Hawkins; W K Engel
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.